Caveolin-1 modulates TGF-β1 signaling in cardiac remodeling

Matrix Biology

Volumn 30, Issue 5-6, 2011, Pages 318-329

  Miyasato, Shelley K ^a   Loeffler, Jorik ^a   Shohet, Ralph ^a   Zhang, Jianhua ^b   Lindsey, Merry ^b   Le Saux, Claude Jourdan ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiac remodeling; Caveolin 1; Cryoinjury; Mouse model; TGF 1 signaling

Indexed keywords

CAVEOLIN 1; COLLAGEN; MESSENGER RNA; MOLECULAR SCAFFOLD; NEUTROPHIL COLLAGENASE; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC REMODELING; COLD INJURY; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE; HEART SURGERY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CAVEOLIN 1; COLLAGEN; CRYOSURGERY; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED C57BL; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; MUS;

EID: 79960561895     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2011.05.003     Document Type: Article

References (43)

1. Augustus A.S., Buchanan J., Gutman E., Rengo G., Pestell R.G., et al. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism. Cell Cycle 2008, 7:2509-2518.
2. Barth K., Gentsch M., Blasche R., Pfuller A., Parshyna I., et al. Distribution of caveolin-1 and connexin43 in normal and injured alveolar epithelial R3/1 cells. Histochem. Cell Biol. 2005, 123:239-247.
3. Bernatchez P.N., Bauer P.M., Yu J., Prendergast J.S., He P., Sessa W.C. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:761-766.
4. Bucci M., Gratton J.P., Rudic R.D., Acevedo L., Roviezzo F., et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 2000, 6:1362-1367.
5. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74:184-195.
6. Bujak M., Ren G., Kweon H.J., Dobaczewski M., Reddy A., et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007, 116:2127-2138.
7. Chen Y.G. Endocytic regulation of TGF-beta signaling. Cell Res. 2009, 19:58-70.
8. Chow A.K., Cena J., El-Yazbi A.F., Crawford B.D., Holt A., et al. Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart. J. Mol. Cell. Cardiol. 2007, 42:896-901.
9. Chow A.K., Daniel E.E., Schulz R. Cardiac function is not significantly diminished in hearts isolated from young caveolin-1 knockout mice. Am. J. Physiol. Heart Circ. Physiol. 2009, 299:H1183-1189.
10. Cohen A.W., Park D.S., Woodman S.E., Williams T.M., Chandra M., et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 2003, 284:C457-C474.
11. Del Galdo F., Lisanti M.P., Jimenez S.A. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 2008, 20:713-719.
12. Duvernelle C., Freund V., Frossard N. Transforming growth factor-beta and its role in asthma. Pulm. Pharmacol. Ther. 2003, 16:181-196.
13. Farhat N., Thorin-Trescases N., Voghel G., Villeneuve L., Mamarbachi M., et al. Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can. J. Physiol. Pharmacol. 2008, 86:761-769.
14. Galdo F.D., Sotgia F., de Almeida C.J., Jasmin J.F., Musick M., et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum. 2008, 58:2854-2865.
15. Hao J., Ju H., Zhao S., Junaid A., Scammell-La Fleur T., Dixon I.M. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J. Mol. Cell. Cardiol. 1999, 31:667-678.
16. Jensen J.A., Kosek J.C., Hunt T.K., Goodson W.H., Miller D.C. Cardiac cryolesions as an experimental model of myocardial wound healing. Ann. Surg. 1987, 206:798-803.
17. Kozera L., White E., Calaghan S. Caveolae act as membrane reserves which limit mechanosensitive I(Cl, swell) channel activation during swelling in the rat ventricular myocyte. PLoS One 2009, 4:e8312.
18. Langlois S., Cowan K.N., Shao Q., Cowan B.J., Laird D.W. Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes. Mol. Biol. Cell 2008, 19:912-928.
19. Le Saux C.J., Teeters K., Miyasato S.K., Hoffmann P.R., Bollt O., et al. Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling. J. Biol. Chem. 2008, 283:5760-5768.
20. Lee E.K., Lee Y.S., Han I.O., Park S.H. Expression of caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells. Biochem. Biophys. Res. Commun. 2007, 359:385-390.
21. Martos R., Baugh J., Ledwidge M., O'Loughlin C., Murphy N.F., et al. Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. Eur. J. Heart Fail. 2009, 11:191-197.
22. Munger J.S., Harpel J.G., Gleizes P.E., Mazzieri R., Nunes I., Rifkin D.B. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int. 1997, 51:1376-1382.
23. Murata T., Lin M.I., Huang Y., Yu J., Bauer P.M., et al. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J. Exp. Med. 2007, 204:2373-2382.
24. O'Quinn M.P., Palatinus J.A., Harris B.S., Hewett K.W., Gourdie R.G. A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury. Circ. Res. 2011, 108:704-715.
25. Patel H.H., Tsutsumi Y.M., Head B.P., Niesman I.R., Jennings M., et al. Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1. FASEB J. 2007, 21:1565-1574.
26. Radauceanu A., Ducki C., Virion J.M., Rossignol P., Mallat Z., et al. Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. J. Card. Fail. 2008, 14:467-474.
27. Razani B., Zhang X.L., Bitzer M., von Gersdorff G., Bottinger E.P., Lisanti M.P. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J. Biol. Chem. 2001, 276:6727-6738.
28. Schubert A.L., Schubert W., Spray D.C., Lisanti M.P. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 2002, 41:5754-5764.
29. Tourkina E., Richard M., Gooz P., Bonner M., Pannu J., et al. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L843-L861.
30. van Amerongen M.J., Harmsen M.C., van Rooijen N., Petersen A.H., van Luyn M.J. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 2007, 170:818-829.
31. van den Bos E.J., Mees B.M., de Waard M.C., de Crom R., Duncker D.J. A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1291-H1300.
32. Vanhoutte D., Heymans S. TIMPs and cardiac remodeling: 'embracing the MMP-independent-side of the family'. J. Mol. Cell. Cardiol. 2009, 48:445-453.
33. Voghel G., Thorin-Trescases N., Farhat N., Nguyen A., Villeneuve L., et al. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech. Ageing Dev. 2007, 128:662-671.
34. Volonte D., McTiernan C.F., Drab M., Kasper M., Galbiati F. Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H392-H401.
35. Wang le F., Patel M., Razavi H.M., Weicker S., Joseph M.G., et al. Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am. J. Respir. Crit. Care Med. 2002, 165:1634-1639.
36. Wang B., Hao J., Jones S.C., Yee M.S., Roth J.C., Dixon I.M. Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1685-H1696.
37. Wang J., Xu N., Feng X., Hou N., Zhang J., et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ. Res. 2005, 97:821-828.
38. Wang X.M., Zhang Y., Kim H.P., Zhou Z., Feghali-Bostwick C.A., et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J. Exp. Med. 2006, 203:2895-2906.
39. Wang B., Omar A., Angelovska T., Drobic V., Rattan S.G., et al. Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1282-H1290.
40. Williams T.M., Medina F., Badano I., Hazan R.B., Hutchinson J., et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem. 2004, 279:51630-51646.
41. Young L.H., Ikeda Y., Lefer A.M. Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2489-H2495.
42. Zhang X.L., Topley N., Ito T., Phillips A. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J. Biol. Chem. 2005, 280:12239-12245.
43. Zhao Y.Y., Liu Y., Stan R.V., Fan L., Gu Y., et al. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:11375-11380.